- Home
- MTC vs CGTX Comparison
MTC vs CGTX Comparison
Compare MTC & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTC
- CGTX
- Stock Information
- Founded
- MTC 2015
- CGTX 2007
- Country
- MTC Hong Kong
- CGTX United States
- Employees
- MTC N/A
- CGTX N/A
- Industry
- MTC Computer Software: Prepackaged Software
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- MTC Technology
- CGTX Health Care
- Exchange
- MTC Nasdaq
- CGTX Nasdaq
- Market Cap
- MTC 36.3M
- CGTX 30.0M
- IPO Year
- MTC 2019
- CGTX 2021
- Fundamental
- Price
- MTC $1.50
- CGTX $0.63
- Analyst Decision
- MTC
- CGTX Strong Buy
- Analyst Count
- MTC 0
- CGTX 6
- Target Price
- MTC N/A
- CGTX $8.30
- AVG Volume (30 Days)
- MTC 127.1K
- CGTX 1.3M
- Earning Date
- MTC 02-11-2025
- CGTX 03-25-2025
- Dividend Yield
- MTC N/A
- CGTX N/A
- EPS Growth
- MTC N/A
- CGTX N/A
- EPS
- MTC 1.16
- CGTX N/A
- Revenue
- MTC N/A
- CGTX N/A
- Revenue This Year
- MTC N/A
- CGTX N/A
- Revenue Next Year
- MTC N/A
- CGTX N/A
- P/E Ratio
- MTC $1.44
- CGTX N/A
- Revenue Growth
- MTC N/A
- CGTX N/A
- 52 Week Low
- MTC $0.18
- CGTX $0.34
- 52 Week High
- MTC $12.90
- CGTX $2.95
- Technical
- Relative Strength Index (RSI)
- MTC 53.25
- CGTX 41.97
- Support Level
- MTC $1.43
- CGTX $0.70
- Resistance Level
- MTC $1.69
- CGTX $0.82
- Average True Range (ATR)
- MTC 0.11
- CGTX 0.06
- MACD
- MTC -0.05
- CGTX -0.02
- Stochastic Oscillator
- MTC 19.35
- CGTX 12.98
About MTC MMTec Inc.
MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. It offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future, MMBD Advisory and HC Securities, and MM Global. It generates maximum revenue from the Gujia segment. Gujia segment provides market data services and investor relations management services to customers in China.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.